Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double‐blind, randomised, placebo‐controlled, phase 2 study

Summary Background Gastroparesis is a serious gastrointestinal (GI) condition characterised by delayed gastric emptying (GE). Velusetrag—a potent, selective, pan‐gastrointestinal 5‐hydroxytryptamine type 4 receptor agonist—is under investigation for treatment of GI motility disorders including gastr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alimentary pharmacology & therapeutics 2021-05, Vol.53 (10), p.1090-1097
Hauptverfasser:	Kuo, Braden, Barnes, Chris N., Nguyen, Deanna D., Shaywitz, David, Grimaldi, Maria, Renzulli, Cecilia, Canafax, Daniel, Parkman, Henry P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Diabetes Diabetes mellitus Double-blind studies Gastric emptying Gastroenterology & Hepatology Life Sciences & Biomedicine Pharmacology & Pharmacy Placebos Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!